Main clinical features in the 20 patients with LGMD2C
| Subject | Sex | Current age (y) | Age at onset (y) | Age at wheelchair confinement (y) | Age at death (y) |
|---|---|---|---|---|---|
| IV.3 | M | 40 | 3 | 18 | — |
| IV.4 | M | — | 3 | 13 | 30 |
| IV.8 | M | 34 | 3 | 18 | — |
| IV.11 | F | 28 | 5 | 20 | — |
| IV.12 | M | 26 | 3 | 13 | — |
| IV.20 | M | 36 | 3 | 15 | — |
| IV.22 | F | 31 | 5 | 30 | — |
| IV.24 | M | — | 3 | 13 | 21 |
| IV.26 | F | 40 | 5 | 19 | — |
| IV.32 | F | — | 4 | 21 | 36 |
| IV.34 | F | 38 | 6 | 23 | — |
| IV.35 | M | — | 6 | 14 | 35 |
| IV.37 | F | — | 6 | 21 | 29 |
| IV.46 | F | 29 | 3 | 20 | — |
| IV.47 | F | 27 | 3 | 20 | — |
| IV.49 | M | 24 | 3 | 14 | — |
| V.4 | M | 12 | 2 | 11 | — |
| V.5 | M | 10 | 2 | 10 | — |
| V.7 | M | 29 | 4 | 14 | — |
| V.18 | F | 27 | 4 | 21 | — |